Gene · 5454
Papers1,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of lymph node metastasis-related prognostic markers in breast cancer. | J Proteomics | 2024 | 37939914 | PubTator, text mining | PubMed |
| Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma. | Genes Dis | 2024 | 37692491 | PubTator, text mining | PubMed |
| Bioactive materials for in vivo sweat gland regeneration. | Bioact Mater | 2024 | 37637080 | PubTator, text mining | PubMed |
| Analyses of the autism-associated neuroligin-3 R451C mutation in human neurons reveal a gain-of-function synaptic mechanism. | Mol Psychiatry | 2024 | 36280753 | PubTator, text mining | PubMed |
| Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models. | Schizophr Res | 2024 | 35835709 | PubTator, text mining | PubMed |
| Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment. | Front Chem | 2023 | 38264122 | PubTator, text mining | PubMed |
Characterization of a loss-of-function NSF attachment protein beta mutation in monozygotic triplets affected with epilepsy and autism using cortical neurons from proband-derived and CRISPR-corrected induced pluripotent stem cell lines. | Front Neurosci | 2023 | 38260021 | PubTator, text mining | PubMed |
| miR-410 Is a Key Regulator of Epithelial-to-Mesenchymal Transition with Biphasic Role in Prostate Cancer. | Cancers (Basel) | 2023 | 38201476 | PubTator, text mining | PubMed |
| CREB1 Facilitates GABAergic Neural Differentiation of Human Mesenchymal Stem Cells through BRN2 for Pain Alleviation and Locomotion Recovery after Spinal Cord Injury. | Cells | 2023 | 38201271 | PubTator, text mining | PubMed |
| Genetic analysis of cognitive preservation in the midwestern Amish reveals a novel locus on chromosome 2. | medRxiv | 2023 | 38168325 | PubTator, text mining | PubMed |
| Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers. | Res Sq | 2023 | 38168280 | PubTator, text mining | PubMed |
| Novel enhancer mediates the RPL36A-HNRNPH2 readthrough loci and GLA gene expressions associated with fabry disease. | Front Genet | 2023 | 38155709 | PubTator, text mining | PubMed |
| Complex Autism Spectrum Disorder in a Patient with a Novel De Novo Heterozygous MYT1L Variant. | Genes (Basel) | 2023 | 38136944 | PubTator, text mining | PubMed |
| Essential transcription factors for induced neuron differentiation. | Nat Commun | 2023 | 38102126 | PubTator, text mining | PubMed |
| ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers. | J Clin Invest | 2023 | 38099497 | PubTator, text mining | PubMed |
| Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma. | Nat Commun | 2023 | 38092728 | PubTator, text mining | PubMed |
| Transition of allele-specific DNA hydroxymethylation at regulatory loci is associated with phenotypic variation in monozygotic twins discordant for psychiatric disorders. | BMC Med | 2023 | 38082312 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine methylation in glioma: recent insights and future directions. | Cell Mol Biol Lett | 2023 | 38072944 | PubTator, text mining | PubMed |
| The circadian regulator PER1 promotes cell reprogramming by inhibiting inflammatory signaling from macrophages. | PLoS Biol | 2023 | 38048364 | PubTator, text mining | PubMed |
| Neurogenesis in primates versus rodents and the value of non-human primate models. | Natl Sci Rev | 2023 | 38025664 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5454/papers?page=5